Allen Holding’s ImmunityBio IBRX Stock Holding History

Allen Holding’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.49M	Hold	687,571	–	–	0.56%	9
2026 Q2	$6.02M	Hold	687,571	–	–	0.59%	9
2026 Q1	$5.27M	Hold	687,571	–	–	0.52%	9
2025 Q4	$1.36M	Hold	687,571	–	–	0.13%	9
2025 Q3	$1.69M	Hold	687,571	–	–	0.16%	9
2025 Q2	$1.82M	Hold	687,571	–	–	0.18%	10
2025 Q1	$2.07M	Hold	687,571	–	–	0.22%	13
2024 Q4	$1.76M	Hold	687,571	–	–	0.19%	13
2024 Q3	$2.56M	Hold	687,571	–	–	0.28%	11
2024 Q2	$4.35M	Hold	687,571	–	–	0.54%	9
2024 Q1	$3.69M	Hold	687,571	–	–	0.46%	11
2023 Q4	$3.45M	Hold	687,571	–	–	0.48%	11
2023 Q3	$1.16M	Hold	687,571	–	–	0.16%	16
2023 Q2	$1.91M	Hold	687,571	–	–	0.26%	14
2023 Q1	$1.25M	Hold	687,571	–	–	0.18%	15
2022 Q4	$3.49M	Hold	687,571	–	–	0.49%	10
2022 Q3	$3.42M	Hold	687,571	–	–	0.54%	10
2022 Q2	$2.56M	Hold	687,571	–	–	0.37%	13
2022 Q1	$3.86M	Hold	687,571	–	–	0.5%	13
2021 Q4	$4.18M	Hold	687,571	–	–	0.56%	13
2021 Q3	$6.7M	Hold	687,571	–	–	0.99%	10
2021 Q2	$9.8M	Buy	+687,571	New	+$11.4M	1.5%	8

Other funds holding IBRX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Allen Holding's IBRX Position: Q3 2026 in Review

Allen Holding held its ImmunityBio (IBRX) position steady in Q3 2026 at 687,571 shares worth $6.49M. The position accounts for 0.56% of the portfolio, ranked #9.

Allen Holding first reported a position in IBRX in Q2 2021 and has held it in 22 quarters since. The position peaked at $9.8M in Q2 2021. 274 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

Allen Holding held 687,571 shares of ImmunityBio worth $6.49M as of Q3 2026.
Allen Holding left its ImmunityBio share count unchanged in Q3 2026.
ImmunityBio made up 0.56% of Allen Holding's portfolio in Q3 2026, its #9 holding.
Allen Holding first reported a position in ImmunityBio in Q2 2021 and has held it in 22 quarters since.
Allen Holding's ImmunityBio position peaked at $9.8M in Q2 2021.
274 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Allen Holding's 13F filing for Q3 2026, filed 3 Nov 2026.